“The global vitreoretinal surgery devices market is estimated to grow at a CAGR of 8.9% from 2014 to 2019. North America accounted for the maximum market share and is growing at a CAGR of 4.3%. Europe accounted for the second-largest share of the global market. The vitreoretinal surgery devices market is further segmented into types (photocoagulation surgery devices, vitrectomy surgery devices, and illumination surgery devices), where the photocoagulation surgery devices segment commands the largest share and shows a comparatively high growth rate among the other segments.
There have been numerous opportunities for the market to grow. These include approvals received by top players and collaborations by the same to increase the technical efficiency of the procedures and to deliver good results in the market. Abbott received U.S. Food and Drug Administration clearance for its iFS Advanced Femtosecond Laser used in corneal and cataract surgeries. The product helps to create bow-shaped or curved arcuate incisions during surgery. The approval strengthened AMO鈥檚 Femtosecond laser technology for ophthalmology and offered an advanced technique for cataract procedures.
The report has also profiled the leading players of this market along with the developments (new product launches and partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in Global Vitreoretinal Surgery Devices market.
The key players in the Global Vitreoretinal surgery device market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.) and many more.
“
